Funding will drive commercialisation of Reactiv8 in critical US market
Company secures FDA approval for its flagship medical device called ReActiv8
Mainstay Medical’s flagship product is now eligible for reimbursement from private health funds
Revenue at Irish medical device company targeting chronic back pain almost doubles
‘Day 100’ meeting reviews status of application’s review
Company submits application for pre-market approval to US regulator
Company insists other data support case for its implanted electrical stimulation device
Company awaits data as it looks to roll-out ReActive8 device to patients in the US
Matthew Onaitis joins medical device company from Cidara Therapeutics
Group completes back pain neurostimulator implants in all 204 patients enrolled in test for device
Company says five centres in Germany and Ireland have implanted patients with ReActiv8
Firm aims to bring its new therapy for chronic lower back pain to key US market
Irish company positive about clinical trial stemming from its ReActiv8-B product
YOU MAY ALSO LIKE...
How does a post-Brexit world shape the identity and relationship of these islands
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices